Differences in characteristics and outcomes after endovascular therapy: A single-center analysis of patients with vertebrobasilar occlusion due to underlying intracranial atherosclerosis disease and embolism

Abstract

Background

Therapeutic strategies and outcomes vary with stroke subtypes for patients with acute vertebrobasilar occlusion (VBAO). This study aimed to compare characteristics and outcomes of VBAO due to intracranial atherosclerotic disease (ICAD) and embolisms and identify baseline predictors of ICAD.

Methods

Patients with VBAO who received endovascular therapy (EVT) were retrospectively analyzed. Participants fulfilling the criteria were classified as the ICAD group (focal stenosis of >70%, or fixed stenosis >50% in addition to either flow and perfusion impairment on angiography or an evident reocclusion tendency) and the embolism group (defined as no evidence of focal significant stenosis after thrombolysis or thrombectomy). Baseline characteristics and outcomes after EVT were compared between the two groups, and logistic regression was performed to explore the factors associated with ICAD.

Results

Among the 133 patients enrolled, 95 (71.4%) patients were categorized in the ICAD group, and 38 (28.6%) in the embolism group. A history of atrial fibrillation (odds ratio (OR) 0.142; 95% confidence interval (CI) (0.028–0.707), p = 0.017), distal basilar artery occlusion (OR 0.107; 95% CI (0.040–0.289), p < 0.001) and V4 segment occlusion (OR 3.423; 95% CI (1.172–9.999), p = 0.024) were independently associated with ICAD. Patients with VBAO due to ICAD had a lower rate of recanalization (81.1% vs 100%, p = 0.004), but the 90-day good clinical outcome was comparable (41.1% vs 50.0%, p = 0.347).

Conclusions

The occlusion sites and a history of atrial fibrillation might be helpful in predicting ICAD in patients with VBAO. Patients with ICAD who were treated by EVT had a lower rate of recanalization but comparable 90-day good outcomes.

Keywords

Endovascular therapy intracranial atherosclerotic disease vertebrobasilar artery occlusion

Get full access to this article

View all access options for this article.

References

Israeli-korn

Schwammenthal

Yonash-Kimchi

et al.

Ischemic stroke due to acute basilar artery occlusion: Proportion and outcomes. Isr Med Assoc J 2010; 12: 671–675.

Mattle

Arnold

Lindsberg

et al.

Basilar artery occlusion. Lancet Neurol 2011; 10: 1002–1014.

Schonewille

Wijman

Michel

et al.

Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): A prospective registry study. Lancet Neurol 2009; 8: 724–730.

Phan

Huo

et al.

Outcomes of endovascular treatment of basilar artery occlusion in the stent retriever era: A systematic review and meta-analysis. J Neurointerv Surg 2016; 8: 1107–1115.

Gorelick

Wong

Bae

et al.

Large artery intracranial occlusive disease: A large worldwide burden but a relatively neglected frontier. Stroke 2008; 39: 2396–2399.

Lee

Hong

Lee

et al.

Endovascular therapy of cerebral arterial occlusions: Intracranial atherosclerosis versus embolism. J Stroke Cerebrovasc Dis 2015; 24: 2074–2080.

Puetz

Sylaja

Coutts

et al.

Extent of hypoattenuation on CT angiography source images predicts functional outcome in patients with basilar artery occlusion. Stroke 2008; 39: 2485–2490.

Archer

Horenstein

. Basilar artery occlusion: Clinical and radiological correlation. Stroke 1977; 8: 383–390.

Alemseged

Shah

Diomedi

et al.

The Basilar Artery on Computed Tomography Angiography prognostic score for basilar artery occlusion. Stroke 2017; 48: 631–637.

10.

Tomsick

Broderick

Carrozella

et al.

Revascularization results in the Interventional Management of Stroke II trial. AJNR Am J Neuroradiol 2008; 29: 582–587.

11.

Saver

Jahan

Levy

et al.

Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): A randomised, parallel-group, non-inferiority trial. Lancet 2012; 380: 1241–1249.

12.

Lee

Yoon

Kim

et al.

Acute basilar artery occlusion: Differences in characteristics and outcomes after endovascular therapy between patients with and without underlying severe atherosclerotic stenosis. AJNR Am J Neuroradiol 2017; 38: 1600–1604.

13.

Kim

Hong

Park

et al.

Effect of intracranial atherosclerotic disease on endovascular treatment for patients with acute vertebrobasilar occlusion. AJNR Am J Neuroradiol 2016; 37: 2072–2078.

14.

Gao

Sun

et al.

Combined use of mechanical thrombectomy with angioplasty and stenting for acute basilar occlusions with underlying severe intracranial vertebrobasilar stenosis: Preliminary experience from a single Chinese center. AJNR Am J Neuroradiol 2015; 36: 1947–1952.

15.

Horie

Tateishi

Morikawa

et al.

Acute stroke with major intracranial vessel occlusion: Characteristics of cardioembolism and atherosclerosis-related in situ stenosis/occlusion. J Clin Neurosci 2016; 32: 24–29.

16.

Miao

Zhang

Shuai

et al.

Thirty-day outcome of a multicenter registry study of stenting for symptomatic intracranial artery stenosis in China. Stroke 2015; 46: 2822–2829.

17.

Al Kasab

Almadidy

Spiotta

et al.

Endovascular treatment for AIS with underlying ICAD. J Neurointerv Surg 2017; 9: 948–951.

18.

Jia

Feng

Liebeskind

et al.

Mechanical thrombectomy and rescue therapy for intracranial large artery occlusion with underlying atherosclerosis. J Neurointerv Surg 2018; 10: 746–750.